Estados Unidos · Bolsa y Finanzas · Bloomberg

Novartis Inks Chinese mRNA-Therapy Deal for Up to $7.8 Billion

Publicado por Bloomberg · Estados Unidos hace 2 h

Novartis AG will license a messenger RNA-based autoimmune therapy from China’s Abogen Biosciences, in a deal worth as much as $7.8 billion.

Leer el artículo completo en Bloomberg Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.bloomberg.com)

También te puede interesar

Trump’s Threat to Ban Diesel Exports Sets Off Global Alarms

Billionaire George Soros has donated $102 million ahead of the midterms—and now the Democrats are coming out ahead

ConocoPhillips Signs 20-Year LNG Deal With Venture Global

U.S. to send third carrier group to Mideast as Trump warns of new Iran strikes

Here’s what happened in crypto today

Business Insider

Milk Bar founder Christina Tosi shares the hiring approach she used to grow her bakery business